• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Defective molybdopterin biosynthesis: clinical heterogeneity associated with molybdenum cofactor deficiency.

作者信息

Mize C, Johnson J L, Rajagopalan K V

机构信息

Department of Pediatrics, University of Texas Southwestern, Dallas 75235-9063, USA.

出版信息

J Inherit Metab Dis. 1995;18(3):283-90. doi: 10.1007/BF00710416.

DOI:10.1007/BF00710416
PMID:7474893
Abstract

A patient with molybdenum cofactor deficiency (producing the biochemical abnormalities associated with deficiencies of sulphite oxidase and xanthine dehydrogenase) clinically expressed Marfan-like habitus with dislocated lenses, vertebral abnormality, learning disability, moderate hemiplegia, increased medial lentiform MRI signal and intermittent microscopic haematuria. S-Sulphocysteine was present in plasma and urine, and the oxidized derivative of a molybdopterin precursor (precursor Z), together with xanthine and hypoxanthine, were elevated in urine. Blood uric acid was < 1 mg/dl, while urinary urothione was not detected. These data indicate a functionally inadequate terminal enzyme for converting precursor Z to active molybdopterin (complementation group B of general molybdenum cofactor deficiency). Although the biochemical parameters were indicative of a severe deficiency state, the patient has survived into the third decade with a less severe clinical spectrum than has generally been associated with this disease.

摘要

相似文献

1
Defective molybdopterin biosynthesis: clinical heterogeneity associated with molybdenum cofactor deficiency.
J Inherit Metab Dis. 1995;18(3):283-90. doi: 10.1007/BF00710416.
2
Effect of allopurinol on the xanthinuria in a patient with molybdenum cofactor deficiency.别嘌醇对钼辅因子缺乏患者黄嘌呤尿症的影响。
Adv Exp Med Biol. 1994;370:375-8. doi: 10.1007/978-1-4615-2584-4_81.
3
Combined deficiency of xanthine oxidase and sulphite oxidase due to a deficiency of molybdenum cofactor.由于钼辅因子缺乏导致的黄嘌呤氧化酶和亚硫酸盐氧化酶联合缺乏。
J Inherit Metab Dis. 1996;19(5):700-1. doi: 10.1007/BF01799850.
4
Biochemical investigation of a child with molybdenum cofactor deficiency.对一名患有钼辅因子缺乏症儿童的生化研究。
Clin Biochem. 1990 Dec;23(6):537-42. doi: 10.1016/0009-9120(90)80046-l.
5
[Molybdenum cofactor deficiency].[钼辅因子缺乏症]
Ryoikibetsu Shokogun Shirizu. 1998(18 Pt 1):474-7.
6
Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor.钼代谢的先天性缺陷:一名缺乏钼辅因子患者中,亚硫酸盐氧化酶和黄嘌呤脱氢酶的联合缺乏。
Proc Natl Acad Sci U S A. 1980 Jun;77(6):3715-9. doi: 10.1073/pnas.77.6.3715.
7
Absence of hepatic molybdenum cofactor: an inborn error of metabolism leading to a combined deficiency of sulphite oxidase and xanthine dehydrogenase.肝钼辅因子缺乏:一种导致亚硫酸盐氧化酶和黄嘌呤脱氢酶联合缺乏的先天性代谢缺陷。
J Inherit Metab Dis. 1983;6 Suppl 1:78-83. doi: 10.1007/BF01811328.
8
Combined xanthine and sulphite oxidase defect due to a deficiency of molybdenum cofactor.由于钼辅因子缺乏导致的联合黄嘌呤和亚硫酸盐氧化酶缺陷。
J Inherit Metab Dis. 1986;9(4):343-7. doi: 10.1007/BF01800483.
9
Molybdenum cofactor deficiency in a patient previously characterized as deficient in sulfite oxidase.钼辅因子缺乏症,该患者之前被诊断为亚硫酸盐氧化酶缺乏。
Biochem Med Metab Biol. 1988 Aug;40(1):86-93. doi: 10.1016/0885-4505(88)90108-9.
10
[Xanthine oxidase deficiency (hereditary xanthinuria), molybdenum cofactor deficiency].[黄嘌呤氧化酶缺乏症(遗传性黄嘌呤尿症),钼辅因子缺乏症]
Nihon Rinsho. 1996 Dec;54(12):3333-6.

引用本文的文献

1
A prevalent MOCS2 variant in the Roma population is associated with a novel mild form of molybdenum cofactor deficiency.罗姆人群中一种常见的MOCS2变体与一种新型轻度钼辅因子缺乏症相关。
Eur J Pediatr. 2025 Jul 25;184(8):499. doi: 10.1007/s00431-025-06335-x.
2
The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with mutation.饮食蛋白质限制对一例伴有突变的钼辅因子缺乏症的影响。
Mol Genet Metab Rep. 2021 Feb 1;26:100716. doi: 10.1016/j.ymgmr.2021.100716. eCollection 2021 Mar.
3
Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature.

本文引用的文献

1
An HPLC assay for detection of elevated urinary S-sulphocysteine, a metabolic marker of sulphite oxidase deficiency.一种用于检测尿中S-磺基半胱氨酸升高的高效液相色谱法,S-磺基半胱氨酸是亚硫酸盐氧化酶缺乏的一种代谢标志物。
J Inherit Metab Dis. 1995;18(1):40-7. doi: 10.1007/BF00711371.
2
The determination of oxalate in urine and urinary calculi by a new ion-chromatographic technique.
Clin Chim Acta. 1982 Nov 24;126(1):91-9. doi: 10.1016/0009-8981(82)90364-3.
3
Structural and metabolic relationship between the molybdenum cofactor and urothione.钼辅因子与尿硫酮之间的结构和代谢关系。
钼辅因子缺乏症的轻度表型:一位新患者及文献复习。
Mol Genet Genomic Med. 2019 Jun;7(6):e657. doi: 10.1002/mgg3.657. Epub 2019 Mar 21.
4
Arachnomelia syndrome in Simmental cattle is caused by a homozygous 2-bp deletion in the molybdenum cofactor synthesis step 1 gene (MOCS1).西门塔尔牛的蜘蛛指(趾)综合征是由钼辅因子合成步骤 1 基因(MOCS1)中的纯合 2 碱基缺失引起的。
BMC Genet. 2011 Jan 21;12:11. doi: 10.1186/1471-2156-12-11.
5
Synthesis, characterization, and spectroscopy of model molybdopterin complexes.模型钼蝶呤配合物的合成、表征及光谱分析
J Inorg Biochem. 2007 Nov;101(11-12):1601-16. doi: 10.1016/j.jinorgbio.2007.07.012. Epub 2007 Jul 21.
Proc Natl Acad Sci U S A. 1982 Nov;79(22):6856-60. doi: 10.1073/pnas.79.22.6856.
4
Separation and quantitation of oxypurines by isocratic high-pressure liquid chromatography: application to xanthinuria and the Lesch-Nyhan syndrome.等度高压液相色谱法分离和定量氧嘌呤:在黄嘌呤尿症和莱施-奈恩综合征中的应用。
Biochem Med. 1983 Oct;30(2):261-70. doi: 10.1016/0006-2944(83)90092-3.
5
Molybdenum cofactor deficiency in a patient previously characterized as deficient in sulfite oxidase.钼辅因子缺乏症,该患者之前被诊断为亚硫酸盐氧化酶缺乏。
Biochem Med Metab Biol. 1988 Aug;40(1):86-93. doi: 10.1016/0885-4505(88)90108-9.
6
Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor.人类中的钼辅因子生物合成。对钼辅因子缺乏患者的两个互补组的鉴定以及一种可扩散的钼蝶呤前体的初步表征。
J Clin Invest. 1989 Mar;83(3):897-903. doi: 10.1172/JCI113974.
7
The pterin molybdenum cofactors.蝶呤钼辅因子。
J Biol Chem. 1992 May 25;267(15):10199-202.
8
Sulfite oxidase deficiency. Biochemical and clinical investigations of a hereditary metabolic disorder in sulfur metabolism.
N Engl J Med. 1977 Nov 10;297(19):1022-8. doi: 10.1056/NEJM197711102971902.